Cited 0 times in Scipus Cited Count

Lymphopenia as a Potential Predictor of Ipsilateral Breast Tumor Recurrence in Early Breast Cancer

DC Field Value Language
dc.contributor.authorCho, O-
dc.contributor.authorChun, M-
dc.contributor.authorKim, SW-
dc.contributor.authorJung, YS-
dc.contributor.authorYim, H-
dc.date.accessioned2022-01-14T05:16:22Z-
dc.date.available2022-01-14T05:16:22Z-
dc.date.issued2019-
dc.identifier.issn0250-7005-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/19951-
dc.description.abstractBACKGROUND/AIM: The aim of this study was to investigate the association between lymphopenia after breast conserving therapy (BCT) and ipsilateral breast tumor recurrence (IBTR) in early breast cancer (EBC).
PATIENTS AND METHODS: We examined 216 EBC patients treated with partial mastectomy followed by radiotherapy (RT), none of whom received chemotherapy. Absolute lymphocyte counts (ALCs) during the two years after RT were collected from each patient: pretreatment ALC, ALC at 3-5 months (ALC1), ALC at 9-11 months, ALC at 15-17 months, and ALC at 21-23 months.
RESULTS: The 102 patients with ALC1 1,479 cells/mul (16.2% vs. 1%, p=0.0034). The multivariate analysis showed that age, resection margins, human epidermal growth factor receptor, and lymphopenia were significant predictors of IBTR.
CONCLUSION: Lymphopenia is a potential predictor for IBTR in EBC patients treated with BCT.
-
dc.subject.MESHAdult-
dc.subject.MESHAged-
dc.subject.MESHBreast Neoplasms-
dc.subject.MESHCombined Modality Therapy-
dc.subject.MESHDisease-Free Survival-
dc.subject.MESHFemale-
dc.subject.MESHHumans-
dc.subject.MESHLymphocyte Count-
dc.subject.MESHLymphopenia-
dc.subject.MESHMastectomy-
dc.subject.MESHMastectomy, Segmental-
dc.subject.MESHMiddle Aged-
dc.subject.MESHNeoplasm Recurrence, Local-
dc.subject.MESHRadiotherapy-
dc.subject.MESHRadiotherapy, Adjuvant-
dc.titleLymphopenia as a Potential Predictor of Ipsilateral Breast Tumor Recurrence in Early Breast Cancer-
dc.typeArticle-
dc.identifier.pmid31366546-
dc.subject.keywordBreast cancer-
dc.subject.keywordlymphopenia-
dc.subject.keywordrisk factors-
dc.subject.keywordtumor recurrence-
dc.contributor.affiliatedAuthorCho, O-
dc.contributor.affiliatedAuthorChun, M-
dc.contributor.affiliatedAuthorJung, YS-
dc.contributor.affiliatedAuthorYim, H-
dc.type.localJournal Papers-
dc.identifier.doi10.21873/anticanres.13620-
dc.citation.titleAnticancer research-
dc.citation.volume39-
dc.citation.number8-
dc.citation.date2019-
dc.citation.startPage4467-
dc.citation.endPage4474-
dc.identifier.bibliographicCitationAnticancer research, 39(8). : 4467-4474, 2019-
dc.embargo.liftdate9999-12-31-
dc.embargo.terms9999-12-31-
dc.identifier.eissn1791-7530-
dc.relation.journalidJ002507005-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Radiation Oncology
Journal Papers > School of Medicine / Graduate School of Medicine > Surgery
Journal Papers > School of Medicine / Graduate School of Medicine > Pathology
Files in This Item:
There are no files associated with this item.

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse